Wu, Jashin, Sanjeev Balu, Nikolaj Birk Larsen, Ryan Pulleyblank, Liv Strømkjær, Aron Quah, and Marni Wiseman. “Cost-Per-Responder Analysis of Tralokinumab Versus Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the US and Canada”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s317. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/2397.